Introduction {#s1}
============

Trinucleotide repeat expansions within non-coding regions of RNA cause pathogenesis in a number of human diseases, including myotonic dystrophy type 1 (DM1), fragile X-associate tremor and ataxia syndrome (FXTAS), spinocerebellar ataxia type 8 (SCA8), and Huntington\'s disease-like 2 (HDL2) [@pgen.1001340-Ranum1]-[@pgen.1001340-Li1]. The causative mutations of DM1, SCA8 and HDL2 are CTG repeat expansions. In DM1, the CTG expansion is located within the 3′ untranslated region (3′UTR) of the *dystrophia myotonica-protein kinase* (*DMPK*) gene [@pgen.1001340-Brook1], [@pgen.1001340-Fu1]. The expanded CUG repeat RNA forms ribonuclear foci, and mislocalizes and misregulates RNA binding proteins such as CUG-BP1 and MBNL1 that influence alternative splicing [@pgen.1001340-Philips1]-[@pgen.1001340-Mankodi1]. Similarly, expanded CUG RNA also contributes to pathophysiology of SCA8 and HDL2 [@pgen.1001340-Rudnicki1], [@pgen.1001340-Daughters1]. These findings indicate that CTG-based RNA expansion diseases may have the accumulation of RNA foci, sequestration of MBNL1, and disruption of alternative splicing as common components.

It is now recognized, however, that more than 70% of genomic loci show evidence of transcription from both sense and anti-sense strands in the mammalian genome [@pgen.1001340-Katayama1], thus many of the trinucleotide repeat disease loci may display bidirectional transcription. Indeed, anti-sense transcripts have been detected for most trinucleotide repeat disease loci, including DM1 and SCA8 [@pgen.1001340-Batra1]-[@pgen.1001340-Dion1]. In DM1 cells, the sense and antisense transcripts can cause regional chromatin modification [@pgen.1001340-Cho1]. In SCA8, an antisense CAG transcript can be translated into a polyglutamine-encoding protein [@pgen.1001340-Moseley1]. Given that anti-sense transcription occurs widely in the human genome [@pgen.1001340-Katayama1], [@pgen.1001340-Ge1], [@pgen.1001340-He1], defining the range of potential roles and impact of anti-sense repeat transcripts on trinucleotide repeat diseases may provide novel insight into disease pathogenesis.

Drosophila has proven a powerful system to reveal insight into neurological and neurodegenerative disease with relevance to the human situation [@pgen.1001340-Zoghbi1]-[@pgen.1001340-Bilen1]. Thus, to gain insight into CUG RNA toxicity in the DM1 disease situation, we established transgenic flies that express pure, uninterrupted CTG repeat expansions in the 3′UTR of a control protein DsRed. These flies recapitulate major features of human CUG RNA expansion diseases. Given the finding that ∼70% of genes show anti-sense transcription, we then tested the effect of co-expressing CTG and CAG disease transcripts. These data revealed dramatically enhanced toxicity upon co-expression of these transcripts; studies indicate this is due to the generation of triplet repeat-derived siRNAs which can target other repeat containing transcripts. These findings suggest that sense and anti-sense expanded repeat transcripts may interact *in vivo* to generate small RNAs that may dramatically enhance pathology in disease situations.

Results {#s2}
=======

Expression of expanded CUG RNA causes repeat-length dependent toxicity {#s2a}
----------------------------------------------------------------------

To study CUG repeat RNA toxicity in flies, we generated UAS constructs with a pure CTG repeat expansion of 250 in length, (CTG)250, within the 3′UTR of DsRed ([Figure 1A](#pgen-1001340-g001){ref-type="fig"}). Due to instability of the repeat in *E. coli*, we obtained clones with various repeat lengths and generated a series of transgenic lines that together encompassed a range of CTG repeat lengths ([Figure 1B](#pgen-1001340-g001){ref-type="fig"}). Among these, we selected six lines bearing different repeat lengths that expressed the transcript at comparable levels ([Figure 1C and 1D](#pgen-1001340-g001){ref-type="fig"}).

![CTG repeat transcripts cause repeat-length dependent toxicity.\
A. DNA constructs for DM1 fly model. A pure, uninterrupted CTG repeat was placed in the 3′UTR of a control protein DsRed. B. Southern blot, probed with DsRed sequence, was used to determine CTG repeat length in transgenic lines. *w^1118^* was the negative control. C. Northern blot to determine RNA expression levels. 3′UTR sequence was used as the probe. D. Western blot to compare DsRed protein level. Heat shock, with a *hs-gal4* driver, was used for expression in B--D. E. External eye and internal retinal structure of flies expressing distinct length CTG repeat transcripts at 1d (top panels) and 14d (bottom panels). Genotypes of flies from left to right: *Gmr-gal4* in trans to, *UAS-DsRed-(CTG)19*, *UAS-DsRed-(CTG)130*, *UAS-DsRed-(CTG)200*, *UAS-DsRed-(CTG)230*, *UAS-DsRed-(CTG)270*. The effect of *UAS-DsRed-(CTG)270* was variable (see also [Figure S1](#pgen.1001340.s001){ref-type="supplementary-material"}); shown here are examples of mild (m) and severe (s) effects. Arrows highlight necrotic patches on external eyes and loss of retinal tissue internally.](pgen.1001340.g001){#pgen-1001340-g001}

With expression ubiquitously using *daughterless-gal4* (*da-gal4*), in the nervous system with *elav-gal4*, or in muscle with *24B-gal4,* repeat-length dependent lethality was observed ([Table 1](#pgen-1001340-t001){ref-type="table"}). When expression was targeted selectively to the eye, the animals showed abnormal eye pigmentation and disruption of retinal integrity, the severity of which was dependent on repeat length ([Figure 1E](#pgen-1001340-g001){ref-type="fig"}). Flies bearing the longest repeats also showed variability in severity which may be a feature of a pure repeat sequence ([Figure 1E](#pgen-1001340-g001){ref-type="fig"} and [Figure S1](#pgen.1001340.s001){ref-type="supplementary-material"}, see [Discussion](#s3){ref-type="sec"}). Taken together, these studies indicate that non-coding, uninterrupted CTG repeats confer length-dependent toxicity when expressed in brain and muscle in flies. As in mammals, the expanded CTG repeat transcripts formed RNA accumulations in muscle nuclei in flies ([Figure S2](#pgen.1001340.s002){ref-type="supplementary-material"}; also [@pgen.1001340-Houseley1], [@pgen.1001340-deHaro1]), and affected alternative splicing ([Figure S2B and S2C](#pgen.1001340.s002){ref-type="supplementary-material"}). These data indicate that the fly recapitulates fundamental key features of the CTG expansion disease DM1 (also [@pgen.1001340-Houseley1]-[@pgen.1001340-GarciaLopez1]).

10.1371/journal.pgen.1001340.t001

###### Length-dependent toxicity of CTG repeats in different tissues.

![](pgen.1001340.t001){#pgen-1001340-t001-1}

  Tissue type    CTG repeat number                       
  ------------- ------------------- --- ---- ----- ----- -----
  muscle                 −           −   −    +/−   +/−   +/−
  neuronal               −           −   \+   ++    ++    ++
  ubiquitous             −           −   ++   ++    ++    ++

Transgenic lines bearing the specific repeat lengths noted were outcrossed to driver *gal4* lines that selectively express in specific tissues. Muscle expression was with *24B-gal4*, neural expression with *elav-gal4*, and ubiquitous expression with *da-gal4*.

Key: −, viable; +/−, semi-lethal; +, pupal lethal; ++, larval lethal.

Enhancement of CTG-repeat toxicity by CAG-repeat transcripts {#s2b}
------------------------------------------------------------

Bi-directional transcription is prevalent in the mammalian genome and is thought to occur in DM1 [@pgen.1001340-Katayama1], [@pgen.1001340-Batra1], [@pgen.1001340-Cho1], [@pgen.1001340-Dion1]. We therefore asked whether expression of a non-coding CAG repeat transcript together with a CTG repeat transcript would have an effect distinct from that of the CTG repeat transcript alone.

Toxicity of non-coding (CAG)250 repeat transcripts has been previously characterized, as adult-stage late-onset neurological dysfunction and loss [@pgen.1001340-Li2]. Expression of either (CAG)250 or (CTG)200 in the eye with *gmr-gal4*, however, causes minimal effects ([Figure 1E](#pgen-1001340-g001){ref-type="fig"}) [@pgen.1001340-Li2]. Co-expression of (CTG)200 together with a (CAG)250 transcript, however, resulted in dramatic toxicity: the eye was now severely rough with abnormal pigmentation, demonstrating severe loss of retinal integrity ([Figure 2A](#pgen-1001340-g002){ref-type="fig"}). The effect was synergistic, as expression of either two copies of a (CAG)250 or two copies of (CTG)200 repeat alone had limited or no effects ([Figure S3](#pgen.1001340.s003){ref-type="supplementary-material"}). Additional combinations of repeat lengths with *gmr-gal4* indicated that co-expression of (CTG)250 or (CTG)270 with (CAG)250 repeats caused lethality at pre-adult pupal stages and/or generated adults with severely disrupted eyes, depending upon the precise combination of transgenes ([Figure 3A and 3D](#pgen-1001340-g003){ref-type="fig"}, and data not shown). The interaction was dependent on disease-length repeat expansions, since flies co-expressing small (CTG)19 and (CAG)34 repeats did not show toxicity ([Figure 2A](#pgen-1001340-g002){ref-type="fig"}).

![Interaction between expanded CAG and CTG repeat transcripts causes biogenesis of small RNAs.\
A. External eye (top) and internal retinal sections (bottom). Left, co-expression of transgenes with short repeats shows no deleterious effect. Right, co-expression of expanded (CAG)250 with expanded (CTG)200 repeat transcripts leads to a disrupted eye externally, with severe loss of retinal integrity internally. Genotypes: left, *gmr-gal4* in trans to *UAS-DsRed-(CTG)19 UAS-DsRed-(CAG)34* and right, *gmr-gal4, UAS-DsRed-(CTG)200/+; UAS-DsRed-(CAG)250/+.* Age of flies: 1d. B. Northern blot. The expression level of the (CTG)250 transcript is reduced when co-expressed with the (CAG)250 transcript. \*: a non-specific band overlapping with Dsred-(CTG)19. C. Small repeat RNAs were generated when expanded CAG and CTG repeat transcripts were co-expressed. Genotype of flies in B and C: *hs-gal4* in trans to *UAS-DsRed-(CTG)19 UAS-DsRed-(CAG)34, w^1118^, UAS-DsRed, UAS-DsRed-(CAG)250, UAS-DsRed-(CTG)250* and *UAS-DsRed-(CAG)250 UAS-DsRed-(CTG)250.*](pgen.1001340.g002){#pgen-1001340-g002}

![Toxicity and small RNA biogenesis of co-expressed CTG and CAG transcripts are dependent on *dcr2* and *ago2*.\
A. Loss of *dcr2* rescues the toxicity caused by co-expression of (CAG)250 and (CTG)250. With normal *dcr2* gene function (wildtype), (CAG)250(CTG)250 caused lethality at the pre-adult pupal stage, with dissected animals showing severely disrupted eyes externally and internally. In the *dcr2* null background, these flies were now viable and displayed a dramatically improved retinal structure. Genotypes: *gmr-gal4* in trans to *UAS-DsRed-(CTG)250 UAS-DsRed-(CAG)250* in normal or homozygous *dcr2* null background. Age of flies: 1d. B. Mutation of *dcr2* also rescued lethality of flies co-expressing expanded repeat transcripts. Survival of adult flies was scored 50 hr after 30 min heatshock induction of transgene expression with *hs-gal4*. \*: *p*\<0.01 when compared to *dcr2* null background. ANOVA and Newman-Keuls post-test. Genotypes: *hs-gal4* in trans to *UAS-DsRed-(CAG)34 UAS-DsRed-(CTG)19, 2xUAS-DsRed-(CAG)250, 2xUAS-DsRed-(CTG)250*, and *UAS-DsRed-(CAG)250 UAS-DsRed-(CTG)250* in normal or homozygous *dcr2* background. C. Co-expression of (CAG)100 and (CTG)130 in muscle with *24B-gal4* leads to developmental lethality, which is rescued by *dcr2* mutation. Genotype of parental flies: *24B-gal4* ∶ *UAS-DsRed-(CAG)34 UAS-DsRed-(CTG)19/TM6B, Tb*. *24B-gal4* ∶ *2xUAS-DsRed-(CTG)130/TM6B, Tb*. *24B-gal4/TM6B, Tb* ∶ *2xUAS-DsRed-(CAG)100*. *24B-gal4* ∶ *2xUAS-DsRed-(CAG)100 UAS-DsRed-(CTG)130/ TM6B, Tb*. *dcr2^L811fsX^; 24B-gal4/ TM6B, Tb* ∶ *dcr2^L811fsX^; UAS-DsRed-(CAG)100 UAS-DsRed-(CTG)130/TM6B, Tb*. \*: *p*\<0.05 when compared to flies in wildtype background. ANOVA and Newman-Keuls post-test. D. Homozygous loss *ago2* suppressed the toxicity caused by co-expression of (CAG)250 and (CTG)200, with flies showing improved external eye. Flies were raised at 29 °C. Age of flies: 1d. Genotypes: *gmr-gal4* in trans to *UAS-DsRed-(CAG)250 UAS-DsRed-(CTG)200* in normal or homozygous *ago2* null background. E. Loss of *dcr2* restored levels of full-length repeat transcripts. Head RNA was subject to Northern blot. 18S rRNA, loading control. F. Biogenesis of triplet repeat-derived small RNAs is dcr2-dependent. Small RNA isolated from fly heads was analyzed by Northern blot. 2S rRNA, loading control. Genotypes E and F: *hs-gal4* in trans to *UAS-DsRed-(CAG)250 UAS-DsRed-(CTG)250* in wildtype or *dcr2* null background. G. Triplet repeat-derived small RNAs were methylated at the 3′ end by Hen1 shown by oxidation and ß-elimination reactions. Small RNA from heads was analyzed by Northern blot and probed with (CAG)5. Note that triplet repeat-derived small RNAs from *hen1* null mutants run as a range of faster-migrating species after ß-elimination. 2S rRNA blot served as the control. Genotype: *hs-gal4* in trans to *UAS-DsRed-(CAG)250 UAS-DsRed-(CTG)270.*](pgen.1001340.g003){#pgen-1001340-g003}

A toxic interaction between CTG/CAG transcripts was also seen using a heat shock driver in adults, and a muscle driver 24B. Adult flies with a 30 min heat shock induction of (CAG)250 and (CTG)250 transcripts started to die at ∼24 h, with 90% flies dead at 50 h ([Figure 3B](#pgen-1001340-g003){ref-type="fig"}). In contrast, flies expressing (CAG)250 alone, (CTG)250 alone or non-pathogenic (CTG)19/(CAG)34 transcripts were not affected. In muscle, co-expression of (CAG)100 with (CTG)130 caused developmental lethality, while (CTG)19/(CAG)34, (CAG)100, and (CTG)130 flies were viable ([Figure 3C](#pgen-1001340-g003){ref-type="fig"}). Taken together, these data indicate that co-expression of disease-length CTG repeat transcripts together with comparable CAG repeat transcripts causes synergistic pathogenesis.

CTG/CAG transcripts are processed into small RNAs {#s2c}
-------------------------------------------------

To define the basis of the enhanced toxicity upon co-expressed CTG and CAG transcripts, we reasoned that the stability of each transcript may become greater, such that each transcript then displays greater toxicity. However, northern analysis indicated that the levels of the full-length repeat mRNAs were reduced ([Figure 2B](#pgen-1001340-g002){ref-type="fig"} and [Figure S4A](#pgen.1001340.s004){ref-type="supplementary-material"}), arguing against increased transcript stability accounting for the enhanced toxicity.

A second possibility was that novel interactions between the two transcripts were taking place, causing an effect distinct from either transcript on its own. Small RNA northern analysis revealed that small RNAs of ∼21 nt, detected with either (CAG)5 or (CUG)5 probes, were generated in the co-expression situation ([Figure 2C](#pgen-1001340-g002){ref-type="fig"} and [Figure S4B](#pgen.1001340.s004){ref-type="supplementary-material"}). These data indicated that expanded CAG and CTG transcripts are processed into triplet repeat-derived small RNAs when co-expressed.

Toxicity of co-expressed CTG/CAG transcripts is dependent on Dcr2 and Ago2 {#s2d}
--------------------------------------------------------------------------

Given that the CTG/CAG transcripts produced small RNAs, we determined whether the enhanced toxicity as well as generation of the small RNAs were dependent on *dcr2*, the enzyme in flies that cleaves double-stranded RNA for siRNA biogenesis[@pgen.1001340-Lee1]. Flies expressing (CTG)250/(CAG)250 with *gmr-gal4* were lethal at late developmental stages; dissection of animals from the pupal case revealed severely disrupted eye morphology ([Figure 3A](#pgen-1001340-g003){ref-type="fig"}). Flies expressing the repeat transcripts, but homozygous mutant for *dcr2* gene function, were now viable and displayed significantly restored eye structure ([Figure 3A](#pgen-1001340-g003){ref-type="fig"}). Homozygous loss of *dcr2* activity also rescued organismal lethality with heatshock induction of (CTG)250/(CAG)250 transcripts, and rescued developmental lethality upon expression of (CTG)130/(CAG)100 transcripts in muscle ([Figure 3B and 3C](#pgen-1001340-g003){ref-type="fig"}). Loss of *dcr2* had a minimal or no effect on toxicity of (CTG)250 alone, (CAG)250 alone or a mutant tau protein, the latter being associated with frontotemporal dementia ([Figure S5A and S5B](#pgen.1001340.s005){ref-type="supplementary-material"} and data not shown). This indicates that *dcr2* function is required for the toxicity associated with CTG/CAG co-expression. The *dcr2* null background also blocked the biogenesis of the triplet repeat-derived small RNAs generated upon co-expression of the two transcripts, restoring the full length repeat RNA levels, concomitant with mitigation of toxicity ([Figure 3E and 3F](#pgen-1001340-g003){ref-type="fig"}).

To characterize the triplet repeat-derived small RNAs, we asked whether they were methylated at the 3′ end, a modification specific to siRNAs loaded to Ago2-RISC [@pgen.1001340-Horwich1]. They were resistant to oxidation/ß-elimination normally, but sensitive to ß-elimination in the *hen1* mutant background which prevents methylation ([Figure 3G](#pgen-1001340-g003){ref-type="fig"} and [Figure S4C](#pgen.1001340.s004){ref-type="supplementary-material"}), arguing that the repeat-derived small RNAs are siRNAs and are assembled into the Ago2-RISC complex. Further, loss of *ago2* also dramatically mitigated (CTG)200/(CAG)250 toxicity ([Figure 3D](#pgen-1001340-g003){ref-type="fig"} and [Figure S6](#pgen.1001340.s006){ref-type="supplementary-material"}). To address specificity, we determined whether genes that modulate the miRNA pathway contributed to the CTG/CAG interaction. Reduction in gene dosage of *dcr1* or *ago1* showed no effect (data not shown). In addition, whereas upregulation of *dcr2* dramatically enhanced CTG/CAG toxicity with concomitant increase of the triplet repeat-derived small RNAs, there was no effect of *dcr1* upregulation ([Figure S7](#pgen.1001340.s007){ref-type="supplementary-material"}). These data suggest that the triplet repeat-derived small RNAs are siRNAs in nature and that their toxic effects are dependent on Dcr2 and Ago2 activity.

Triplet repeat derived siRNAs compromise the expression of genes containing short CAG stretches {#s2e}
-----------------------------------------------------------------------------------------------

We tested whether the siRNAs may be competing with endogenous small RNAs for the biogenesis machinery, and thus by a titration mechanism causing toxicity. However, up-regulation of *dcr2,* which should suppress according to a titration mechanism, instead enhanced toxicity of expanded CTG/CAG (see [Figure S7](#pgen.1001340.s007){ref-type="supplementary-material"}). Moreover, generation of miRNAs, with analysis of *miR-277* and *miR-8*, and generation of endogenous small RNAs, with analysis of *hp*-*CG4068B* and *esiRNA-sl-1* (dependent on *dcr2* activity [@pgen.1001340-Czech1]), were not affected upon co-expression of the CTG/CAG transcripts ([Figure 4A](#pgen-1001340-g004){ref-type="fig"}). Transcription of retrotransposon 412 was also not affected in flies expressing expanded CTG/CAG ([Figure 4B](#pgen-1001340-g004){ref-type="fig"}), suggesting that the RNA interference pathways in these flies were largely intact. Together, these data argue that overwhelming endogenous RNA interference pathways cannot account for the enhanced toxicity.

![Expression of expanded (CAG) and (CTG) repeat transcripts disrupts expression of genes containing short triplet repeat stretches.\
A. Biogenesis of the endogenous siRNAs, *hp4068B* and *esiRNA-sl-1*, and microRNAs, *miR-277 and miR-8*, is not affected in flies co-expressing CAG with CTG repeat transcripts. Genotypes: *Hs-gal4* in trans to *UAS-DsRed-(CAG)34 UAS-DsRed-(CTG)19*, *w^1118^*, *UAS-DsRed, UAS-DsRed-(CAG)250, UAS-DsRed-(CTG)250* and *UAS-DsRed-(CAG)250 UAS-DsRed-(CAG)250*. B. Levels of transcripts containing short (CAG) stretches are reduced in flies co-expressing (CAG)250(CTG)250. Two transcripts containing at least five consecutive (CAG) repeats, *atx2* and *tbp*, were chosen for analysis. Retrotransposon *412*, *ß-tubulin* and *appl* were included as controls. Realtime PCR on fly head RNA, 9 hr after heat shock. Genotypes: *Hs-gal4* in trans to *UAS-DsRed, UAS-DsRed-(CAG)250, UAS-DsRed-(CTG)250, UAS-DsRed-(CAG)250 UAS-DsRed-(CAG)250*. (\*: p\<0.01, \*\*: p\<0.001, compared to DsRed. ANOVA and Bonferroni\'s post test, *n* = 4). C. Dicer-2 dependent cleavage of transcripts of *tbp* and *atx2* in flies co-expressing expanded CAG/CTG transcripts as determined by RLM-RACE assay. Genotypes: *hs-gal4* in trans to: *w^1118^, UAS-DsRed-(CAG)34 UAS-DsRed-(CTG)19* and *UAS-DsRED-(CAG)250 UAS-DsRED-(CTG)250* in either wild type or *dcr2* null background. Nested PCR products were analyzed on agarose gels; bands labeled with asterisk were reproducible among four repeat experiments. They were sequenced and confirmed to be derived from cleaved transcripts of *atx2* and *tbp*. D. Cleavage sites on transcripts of *atx2* and *tbp* mapped by sequence analysis of PCR products of the RLM-RACE assay. Frequencies of cleavage at certain sites are shown in the linear map of *atx2* and *tbp* transcripts. Black boxes represent CAG rich regions. *Atx2* has multiple splicing isoforms and isoform B is the form abundantly expressed in fly heads. E. A model for repeat toxicity in CTG diseases that includes possibility of anti-sense CAG transcripts. Sense transcripts containing the CUG repeat RNA expansion exert toxicity through misregulation of RNA binding proteins such as Muscleblind and CUG-BP1, resulting in aberrant alternative splicing [@pgen.1001340-Ranum1], [@pgen.1001340-Savkur1], [@pgen.1001340-Daughters1], [@pgen.1001340-Moseley1], [@pgen.1001340-Koob1]. Antisense transcripts containing CAG repeat expansions could be translated into toxic polyglutamine proteins (as in SCA8 [@pgen.1001340-Moseley1]) and they may also be toxic on their own [@pgen.1001340-Li2]. Our data here suggest that CTG and CAG transcripts may also interact, leading to the generation of ∼21 nt triplet repeat derived siRNAs, which may target other transcripts that contain CAG repeat stretches through the RNA interference pathway.](pgen.1001340.g004){#pgen-1001340-g004}

In light of the requirement for *ago2* and *dcr2*, we then asked whether the triplet repeat-derived siRNAs targeted other transcripts with small CAG or CUG stretches, such that disruption or loss of the activity of those genes may subsequently caused the deleterious effects. We selected two endogenous fly genes which, like their human counterparts, contain CAG repeat stretches, *atx2* (containing (CAG)~9~) and *tbp* (containing (CAG)~5~CAA(CAG)~2~), and analyzed their expression levels by realtime PCR. In flies expressing expanded CTG/CAG transcripts, the levels of these CAG-containing mRNAs were downregulated ∼60--70%; transcripts without such repeats and control transcripts such as *tubulin* and *appl* were unaffected ([Figure 4B](#pgen-1001340-g004){ref-type="fig"}). Further analysis revealed that the *atx2* and *tbp* transcripts were being cleaved within their CAG repeat stretches in flies expressing expanded CTG/CAG repeats in a *dcr-2* dependent manner ([Figure 4C and 4D](#pgen-1001340-g004){ref-type="fig"}). In contrast, we did not observe down-regulation of CUG containing transcripts by realtime PCR nor did we detect cleavage of these transcripts by RLM-RACE in flies expressing expanded CTG/CAG (data not shown; see [Discussion](#s3){ref-type="sec"}). These data indicate that co-expression of CTG/CAG repeat transcripts generates triplet repeat-derived siRNAs that target other CAG-containing transcripts within the genome; deleterious effects on the levels and activity of these genes may contribute to the pathogenic effects of genes with expanded repeats that are bi-directionally transcribed.

Discussion {#s3}
==========

Like many genes within the mammalian genome [@pgen.1001340-Katayama1], the DM1 gene displays bi-directional transcription, generating an anti-sense CAG repeat transcript in addition to the disease-associated CTG transcript [@pgen.1001340-Cho1]. These transcripts have been shown to interact in human cells to generate small RNAs, with one effect being local gene silencing [@pgen.1001340-Cho1]; however additional ways in which this may contribute to pathogenicity in disease is largely unknown. In order to provide new insight into DM1, we generated a *Drosophila* model by expressing pure, uninterrupted CTG repeat expansions; fly models for various disorders have revealed critical insight into a number of human disease situations (Clark et al., 2006; Fernandez-Funez et al., 2000; Jin et al., 2003; Meulener et al., 2005; Warrick et al., 1998). Interestingly, targeted expression of the long CTG repeats in the fly eye caused a variable toxic effect (see [Figure S1](#pgen.1001340.s001){ref-type="supplementary-material"}). This was also observed in a fly model of SCA8, which carries an uninterrupted CTG repeat expansion [@pgen.1001340-Mutsuddi1]. In contrast, fly models generated using interrupted CTG repeats were not reported to show variable phenotype [@pgen.1001340-deHaro1], [@pgen.1001340-GarciaLopez1]. It is thus possible that phenotypic variability may be a feature of pure repeat sequences, which is in line with the fact that DM1 is among the most variable human disorders. To define potential effects of bi-directional transcription, we then co-expressed expanded CAG repeat transcripts with the DM1 CTG repeats. This resulted in dramatically enhanced toxicity concomitant with the generation of triplet repeat-derived siRNAs. Our results are in striking contrast with previous findings that co-expression of CGG and CCG expansions in flies leads to mitigated toxicity in a *ago2*-dependent manner [@pgen.1001340-Sofola1], suggesting that toxicity derived from interactions between sense and anti-sense repeat transcripts may be specific to CTG/CAG situations. Both CAG and CUG strands can be processed into ∼21 nt small RNAs when coexpressed and small RNAs derived from both strands are methylated in a *Hen1*-dependent manner (see [Figure 2C](#pgen-1001340-g002){ref-type="fig"}, [Figure 3G](#pgen-1001340-g003){ref-type="fig"}, [Figure S4B and S4C](#pgen.1001340.s004){ref-type="supplementary-material"}). These results suggest that both CAG and CUG small RNAs can be loaded into mature, holo-RISCs presumably due to the symmetrical thermodynamic properties of the repeat small RNA duplex [@pgen.1001340-Horwich1], [@pgen.1001340-Schwarz1]-[@pgen.1001340-Hutvagner1]. In our studies, we detected direct cleavage of CAG containing transcripts, and we were unable to detect cleavage of CUG containing transcripts mediated by CAG small RNAs (see [Figure 4B--4D](#pgen-1001340-g004){ref-type="fig"}). Although underlying reasons for this differential effect remain unclear, CUG and CAG transcripts may have differential expression levels or translation efficiencies, and/or CUG-containing and CAG-containing transcripts may be associated with different RNA binding proteins of various affinities, making CUG-transcripts less accessible to the RISC complex than CAG-containing transcripts [@pgen.1001340-Pei1]. A number of CUG-binding proteins have been defined, such as MBNL1, CUGBP1 and PKR [@pgen.1001340-Miller1]-[@pgen.1001340-Tian1]. Interestingly, in-vitro gel retardation analysis indicated that MBNL1 has a much lower affinity for CAG repeat RNA than CUG repeat RNA[@pgen.1001340-Miller1]. Moreover, expanded CAG transcripts, although co-localizing with MBNL1 in ribonuclear foci similarly to expanded CUG transcripts, do not appear to cause mis-regulation of alternative splicing in cells[@pgen.1001340-Ho1], further highlighting differential properties of these repeats in interacting with RNA binding proteins.

The toxicity caused by co-expression of expanded CAG and CTG was associated with deleterious effects on transcripts of other CAG containing genes within the genome; additional mechanisms that contribute to toxicity may also exist. A large number of genes contain CAG stretches in fly and human genomes ([Table S1](#pgen.1001340.s008){ref-type="supplementary-material"} and [Table S2](#pgen.1001340.s009){ref-type="supplementary-material"}). The enhanced toxicity we observed in flies expressing expanded CAG and CTG may therefore be reflecting an additive effect of knockdown of multiple CAG-containing genes, with each individual gene contributing only partially to the overall outcome. Although further reducing atx2 dosage did not enhance toxicity of co-expressed CTG/CAG expansions (ZY and NB, unpublished observations), the compromised activities of many target genes may be involved and further compromising any single one has minimal impact. The toxic effects seen of the CAG/CTG situation may also be complicated by the later-onset and progressive nature of the toxicity. Further study will clarify the contribution of this mechanism, and key targets among all possible transcripts, to the overall phenotype of the disease. Moreover, the deleterious effects caused by triplet repeat derived small RNAs may be further exacerbated by the wide prevalence of CAG stretches in the human transcriptome ([Table S2](#pgen.1001340.s009){ref-type="supplementary-material"}) and the relative low specificity of RNA interference when siRNAs and/or RNA targets contain simple repeats like CAG [@pgen.1001340-Jasinska1], [@pgen.1001340-Ma1]. Such interactions may represent a novel activity of endo-siRNAs that characterize disease situations where bi-directional transcription spanning the repeat region occurs ([Figure 4E](#pgen-1001340-g004){ref-type="fig"}).

We confirmed that two of CAG containing genes, *atx2* and *tbp,* are targets of the triplet repeat-derived siRNAs. Interestingly, CAG repeat expansions in *ATXN2* (the human *Ataxin-2 gene*) and *TBP* define two of the CAG-repeat expansion diseases (SCA2 and SCA17, respectively). In such diseases, the expanded polyglutamine domain is thought to confer toxicity [@pgen.1001340-Ranum1], [@pgen.1001340-Orr1]; however, increasing evidence suggests that the loss-of-function of gene activity, and not just dominant activities of the protein with an expanded polyglutamine region, occur in disease [@pgen.1001340-Lim1], [@pgen.1001340-Thomas1]. Our findings raise the possibility that bi-directional transcription of the repeat region in diseases like DM1 may confer additional components of pathogenicity due to deleterious interactions between the two overlapping repeat-containing transcripts through the generation and activity of triplet repeat-derived siRNAs.

Studies indicate that bi-directionally transcribed RNAs, and presumably resultant endogenous double-stranded RNAs, are processed into ∼21--23 nt small RNAs in human cells [@pgen.1001340-Kawaji1], [@pgen.1001340-Yang1]. This is despite the fact that in most mammalian cells, long exogenous double-stranded RNAs can elicit the interferon response [@pgen.1001340-UiTei1], [@pgen.1001340-Caplen1]. That response presumably occurs in a threshold-dependent manner; cells may also respond differentially to long exogenous double-stranded RNAs versus endogenous double-stranded RNAs. Thus, these findings suggest that the biogenesis pathway of small RNAs from endogenous double-stranded RNAs is conserved in mammalian cells. Many loci are bi-directionally transcribed throughout the mammalian genome [@pgen.1001340-Katayama1], [@pgen.1001340-Ge1], [@pgen.1001340-He1], and among these are a number of human trinucleotide disease genes, including SCA8 and DM1 [@pgen.1001340-Batra1], [@pgen.1001340-Dion1]. In SCA8, an anti-sense transcript is proposed to encode a polyglutamine protein, which itself may have deleterious actions [@pgen.1001340-Moseley1]. In DM1, the two transcripts interact to produce small RNAs that can have local effects on gene silencing [@pgen.1001340-Cho1]. Our findings raise another possibility, that processing of co-expressed transcripts containing CUG/CAG expansions into triplet repeat-derived siRNAs *in vivo*, may contribute to toxicity with widespread deleterious effects. These effects may include downregulating the expression of other genes containing CAG repeats. Among the genes that could be targets are the polyglutamine disease genes themselves, one of which is TBP. Expansion of the TBP polyglutamine repeat underlies SCA17 [@pgen.1001340-Nakamura1]; intriguingly, general transcriptional compromise has been shown to be a component of repeat expansion diseases [@pgen.1001340-Freiman1], [@pgen.1001340-Riley1]. Our studies raise the possibility that perhaps another reason why these diseases share transcriptional compromise may be that they share bi-directional transcript interactions that compromise common elements like TBP. This possibility underscores the idea of shared therapeutic targets and mechanisms in repeat expansion diseases.

It has been proposed that siCAG and siCUG may be used for therapy of triplet repeat expansion diseases based on findings in cell culture that these siRNAs seem to specifically target mutant transcripts with expanded repeats [@pgen.1001340-Krol1]. Our data suggest caution in designing such siRNA-based therapy, as in the intact organismal situation, pathogenic activities may be noted. Although previous findings suggest that expanded CUG alone can be processed into small RNAs, [@pgen.1001340-Krol1], our data suggest that both expanded CAG and CTG are required for triplet repeat-derived siRNA generation and toxicity *in vivo* (see [Figure 2C](#pgen-1001340-g002){ref-type="fig"} and [Figure S5](#pgen.1001340.s005){ref-type="supplementary-material"}). Thus, co-expressed CAG and CTG expansions may contribute to DM1 pathogenesis through a fundamentally different mechanism from that of CTG expansions alone. Although our studies were conducted in fly models, the findings may apply to human trinucleotide expansion diseases. Targeting these diseases at the transcriptional level may therefore be a promising therapeutic approach that would minimize not only the effects of single expanded repeat transcripts, but deleterious interactions between sense and anti-sense repeat transcript domains.

Materials and Methods {#s4}
=====================

Fly lines {#s4a}
---------

General fly lines were ordered from public stock centers and maintained at 25 °C on standard medium unless otherwise indicated. CTG repeats of various length (DNA templates kindly provided by C. Thornton, University of Rochester) were inserted into the 3′UTR of DsRed2 gene (Clontech) in pUAST. All transgenic constructs were confirmed by sequencing. Fly lines were generated by P-element mediated transformation. Repeat lengths were determined by Southern blot and confirmed by Genescan for select lines showing variability. dcr2^L811fsX^, ago2^414^, Hen1 mutant Pimet^f00810^, UAS-dcr1, UAS-dcr2, UAS-DsRed-(CAG)100 and UAS-DsRed-(CAG)250 lines are described [@pgen.1001340-Li2], [@pgen.1001340-Lee1], [@pgen.1001340-Okamura1]-[@pgen.1001340-Dietzl1].

Western, Southern, and Northern blots {#s4b}
-------------------------------------

Standard techniques were used. Primary antibodies for Westerns were anti-DsRed (1∶400, anti-rabbit, Clontech), anti-actin (1∶4,000, anti-mouse, Abcam). HRP conjugated secondary anti-mouse (1∶4000, Chemicon) and anti-rabbit antibodies (1∶4000, Zymed) were used with ECL+ reagents (Amersham). For Southern blots, genomic DNA was extracted from ∼50 flies using the Gentra Puregene Cell Kit (Qiagen) and 5 µg of genomic DNA was fully digested with 200 units of EcoRI and XbaI. DsRed DNA was PCR amplified using primers: forward 5′-GGCCCCCTGCCCTTCGCC-3′ and reverse 5′-CTACAGGAACAGGTGGTGGCGG-3′, purified using QIAquick Gel Extraction Kit (Qiagen) and labeled using the High Prime DNA Labeling Kit (Roche Applied Science). For Northern blots, flies were heatshocked at 37 °C for 30 min and allowed to recover at 25 °C for 20 h. Total RNA was extracted using Trizol Reagent (Invitrogen) from either whole flies (for comparing transgene levels among various lines) or heads. 2--10 µg of total RNA was loaded on 1% denaturing formaldehyde/MOPS agarose gels for regular Northern blots. For small RNA Northerns, total RNA was further purified using the mirVana miRNA Isolation Kit (Ambion) to enrich small RNA. 100 ng small RNA was loaded on 15% TBE-Urea polyacrylamide gel (Invitrogen). The SV40 probe for Northern blots was PCR amplified using primers: forward 5′-TGTGGTGTGACATAATTGGACA-3′ and reverse 5′-AGATGGCATTTCTTCTGAGCA-3′, purified using QIAquick Gel Extraction Kit (Qiagen) and labeled using the High Prime DNA Labeling Kit (Roche Applied Science). Other probes for Northern blot were made using the MAXIscript Kit (Ambion) from the annealed double stranded DNA template containing T7 promoter. Oligo sequences were:

T7 promoter forward oligo: 5′-GATAATACGACTCACTATAGGGAGA-3′

r(CAG)5 probe: 5′-GGGGGCTGCTGCTGCTGCTGTCTCCCTATAGTGAGTCGTATTATC-3′

r(CUG)5probe: 5′-GGGGGCAGCAGCAGCAGCAGTCTCCCTATAGTGAGTCGTATTATC-3′

2S rRNA: 5′-TGCTTGGACTACATATGGTTGAGGGTTGTATCTCCCTATAGTGAGTCGTATTATC-3′

18S rRNA: 5′-AGGGAGCCTGAGAAACGGCTACCACATCTAAGGAATCTCCCTATAGTGAGTCGTATTATC-3′

hp4068B: 5′-TTGACTCCAACAAGTTCGCTCCTCTCCCTATAGTGAGTCGTATTATC-3′

mir277: 5′-TAAATGCACTATCTGGTACGACATCTCCCTATAGTGAGTCGTATTATC-3′.

In situ hybridization {#s4c}
---------------------

In-situ hybridization was performed as described [@pgen.1001340-Li2].

Radioactive PCR {#s4d}
---------------

Radioactive PCR for the alternative splicing assay was performed as described [@pgen.1001340-Cooper1]. Total RNA was extracted from fly heads using RNeasy Mini Kit (Qiagen) and cDNA was synthesized using the SuperScript First-Strand Synthesis for RT-PCR (Invitrogen). Primers used for radioactive PCR reaction were: forward 5′-GCCATTTGACCATTCACCACATTGGTGTG-3′, reverse 5′-TTGCTGGAGCATAGCACTCTTCAGGTG-3′. The forward primer was labeled using the T4 polynucleotide kinase (New England Biolabs). PCR reactions were run 21--23 cycles and separated on 5% non-denaturing TBE polyacrylamide gels. The gel was then dried and exposed to Storage Phosphor Screens (GE Healthcare). Band densitometry was quantified using Image J (NIH).

Real-time PCR {#s4e}
-------------

0-3d flies were heatshocked at 37 °C for 30 min and recovered at 25 °C for 9 h. Total RNA was extracted from fly heads using Trizol Reagent (Invitrogen), treated with Turbo DNase (Ambion) and further purified using the mirVana miRNA Isolation Kit (Ambion). cDNA was synthesized in a 20 µl reaction volume from 0.2 µg of total RNA using the High Capacity cDNA Reverse Transcription Kit (Applied Biosystems). 0.2 µl of cDNA was used as the template in a 20 µl reaction volume diluted from the Power SYBR Green PCR Master Mix Kit (Applied Biosystems). Real-time PCR was performed in triplet or quadruplicate using a 7500 Fast Real-Time PCR System (Applied Biosystems). Data were analyzed using the ΔΔCt method. Endogenous control was rp49. Each experiments was repeated at least three times on independent RNA preparations.

Real-time PCR primers were designed using the Primer Express software (Applied Biosystems) and the sequences were:

*atx2* forward: 5′-CGCACGCGCGATAACC-3′

*atx2* reverse: 5′-AGTTGGAAGTCCTGGCCAAA-3′

*tbp* forward: 5′-AAGCTCGGTTTCCCTGCAA-3′

*tbp* reverse: 5′-GCAGGAGCCGACCATGTTT-3′

*412* forward: 5′-CACCGGTTTGGTCGAAAG-3′

*412* reverse: 5′-GGACATGCCTGGTATTTTGG-3′

*appl* forward: AGGTCACGCGCGTTATGAA

*appl* reverse: GGCGCATGTCCTGGTACTTC

*ß-tubulin* forward 5′-CATCCAAGCTGGTCAGTGC-3′

*ß-tubulin* reverse 5′-GCCATGCTCATCGGAGAT-3′

*rp49* forward: 5′-CAACATCGGTTACGGATCGA-3′

*rp49* reverse: 5′-AATCCGGTGGGCAGCAT-3′

RNA ligase mediated amplification of cDNA ends (RLM-RACE) {#s4f}
---------------------------------------------------------

To detect cleavage of *atx2* and *tbp* transcripts, RLM-RACE and cloning of RLM-RACE products were carried out using the GeneRacer Kit (Invitrogen, Carlsbad, CA). Briefly, 3-4d flies were heatshocked at 37 °C for 30 min and then maintained at 25 °C for 14 hr. Total RNA was extracted from fly heads using the RNAeazy kit (Qiagen, Valencia, CA). The 5′ GeneRacer RNA adaptor molecule was ligated onto the total RNA population. Ligated products were reverse transcribed using random primers and nested PCR was performed using primers derived from the 5′ GeneRace adaptor and gene specific primers, respectively, to detect RISC cleavage products. PCR products were analyzed on 1% agarose TAE gel. To analyze cleavage sites, PCR products were gel purified using the gel purification kit (Qiagen, Valencia, CA), cloned using TOPO TA cloning kit (Invitrogen, Carlsbad, CA) and sequenced. Primers used for nested PCR were:

dTBPclv5RACEnest1: 5′-GGGCCCATCGTCTGGTGGATGTT-3′

dTBPclv5RACEnest2: 5′-TGGTGGATGTTGCTCAGGGCATCT-3′

dAtx2clv5RACEnest1: 5′-TGTGGCGGCGGCATTGTATGGTAAA-3′

dAtx2clv5RACEnest2: 5′-TGTGGCGGCGGCTGCTGCACTT-3′

GeneRacer5′ Primer: 5′-CGACTGGAGCACGAGGACACTGA-3′

GeneRacer5′ nested Primer: 5′-GGACACTGACATGGACTGAAGGAGTA-3′

5′ GeneRacer RNA adaptor: 5′-CGACUGGAGCACGAGGACACUGACAUGGACUGAAGGAGUAGAAA-3′

Heatshock survival assay {#s4g}
------------------------

0-3d flies were heat shocked at 37 °C for 30 min and then maintained at 25 °C for 50 hr. Numbers of dead/living flies were recorded. At least ∼100 flies were scored for each genotype and the experiments were repeated three times.

Viability assay {#s4h}
---------------

*24B-gal4* driver flies were outcrossed to flies of appropriate genotype and progeny flies were scored for viability. At least 100 progeny flies were scored for each cross and experiments were repeated three times.

Supporting Information {#s5}
======================

###### 

Variable effect of flies expressing (CTG)270 repeat transcripts in the eye. (A) Representative images of mild, medium and severe eyes of the flies expressing the (CTG)270 repeat in the eye with *gmr-gal4*. Severe were eyes that were smaller in size with more pigmentation loss, less organized and rougher eye surface than flies with mild effects. Retinal sectioning confirmed that the internal retinal structure correlated with the degree of disruption of the external eye. 1d flies of genotype *gmr-gal4/UAS-DsRed-(CTG)270*. (B) Percentage of flies in each category. 740 female flies were scored. Repeat length of parental males was 265--273 by genescan (data not shown). Both male and female flies showed variability; shown here are females.

(1.09 MB TIF)

###### 

Click here for additional data file.

###### 

Expanded CUG repeat RNA accumulate in the nuclei and affect alternative splicing. (A) RNA foci in flies expressing expanded CTG repeat transcript. Body-wall muscles of 3^rd^ instar larvae were stained with propidium iodide to highlight nuclei (left panel), and FAM-labeled (CAG)7 probe for CUG RNA accumulation (right panel). CTG transcripts accumulate in (CTG)230 but not in control (CTG)19 larvae. Foci were sensitive to RNase A but resistant to DNase I treatment. Genotype: *24B-gal4*/*UAS-DsRed-(CTG)230*, *24B-gal4*/*UAS-DsRed-(CTG)19* and *24B-gal4*/*UAS-DsRed-(CTG)270* (B) Structure of the minigene construct for the splicing assay. The human cTNT minigene reporter (kindly provided by T Cooper) was subcloned into pUAST vector for transgenesis. In fly photoreceptor neurons, exon 2 of sTNI was alternatively spliced, resulting in either 110 bp or 140 bp RT-PCR product using the primers indicated. (C) Expression of expanded CUG RNA promoted exclusion of exon 2 of sTNI as indicated by the ratio of 140 bp/110 bp. A representative radioactive gel image was shown on top right corner of the chart. Genotypes: *Rh1-gal4 UAS-hcTNT* in trans to (lane 1) w*^1118^*, (lane 2) *UAS-DsRed-(CTG)19*, (lane 3) *UAS-DsRed-(CTG)270; UAS-DsRed-(CTG)250* and (lane 4) 2x*UAS-DsRed-(CTG)250*. Quantification of 3 independent experiments is shown. (\* *p*\<0.05, \* \* *p*\<0.01 comparing to (CTG)19; ANOVA and Dunnett\'s post test).

(1.35 MB TIF)

###### 

Click here for additional data file.

###### 

Expression of two copies of (CAG)250 or (CTG)200 transcripts alone did not cause an effect as severe as that of co-expression of (CAG)250 together with (CTG)200. External eyes and internal retinal structure. Genotypes: *gmr-gal4* in trans to (left) *2xUAS-DsRed-(CAG)250* and (right) *2xUAS-DsRed-(CTG)200*. Compare to eyes in [Figure 3A](#pgen-1001340-g003){ref-type="fig"}, which shows that co-expression of short CAG and CTG transcripts has no effect, while co-expression of long (CAG)250 with (CTG)200 transcripts is severely toxic. Expression of a single copy of the (CAG)250 transcript in the eye has minimal effects, expression of a single copy of the (CTG)200 transcript is shown in [Figure 1E](#pgen-1001340-g001){ref-type="fig"}.

(1.30 MB TIF)

###### 

Click here for additional data file.

###### 

Repeat derived siRNAs are generated when CTG is co-expressed with CAG. (A) Northern blot. The expression level of the (CAG)250 transcript is reduced when co-expressed with the (CTG)250 transcript. The blot was also probed with DsRed to compare the relative level between (CAG)250 and (CUG)250. (B) ∼21 nt small repeat RNAs were generated as probed by (CUG)5 when expanded CAG and CTG repeats were co-expressed. Genotype: *hs-gal4* in trans to *UAS-DsRed-(CTG)19 UAS-DsRed-(CAG)34, w^1118^, UAS-DsRed, UAS-DsRed-(CAG)250, UAS-DsRed-(CTG)250* and *UAS-DsRed-(CAG)250 UAS-DsRed-(CTG)250* (C) Triplet repeat-derived small CAG RNAs were methylated at the 3′ end by Hen1 shown by oxidation and ß-elimination reactions. Small RNA from heads was analyzed by Northern blot and probed with (CUG)5. 2S rRNA blot served as the control. Genotype: *hs-gal4* in trans to *UAS-DsRed-(CAG)250 UAS-DsRed-(CTG)270.*

(0.55 MB TIF)

###### 

Click here for additional data file.

###### 

Mutations of *dcr2* or *ago2* have minimal effects on toxicity of the expanded CTG transcript and tauR406W. (A) Loss of *dcr2* does not block eye degeneration caused by expression of (CTG)250 transcripts. Arrows highlight black necrotic patches on the eye surface. age of flies: 14d animals. Genotypes: *gmr-gal4, UAS-DsRed-(CTG)250* in normal or homozygous *dcr2* background. (B) Loss of *dcr2* has a minimal effect on toxicity due to expression of mutant tau R406W. Age of flies: 1d. Genotypes: *gmr-gal4, UAS-tauR406W* in normal or homozygous *dcr2* background. (C) Loss of *ago2* does not prevent eye degeneration caused by expression of (CTG)270. Loss of pigmentation and disorganization of ommatidia were similar between wildtype and *ago2* null flies expressing the (CTG)270 transcript. Shown are eyes with severe phenotype in both genotypes. Genotypes: *gmr-gal4, UAS-DsRed-(CTG)270* in normal or homozygous *ago2* background.

(2.30 MB TIF)

###### 

Click here for additional data file.

###### 

Loss of *ago2* suppresses CTG/CAG toxicity. (A) Survival rate of flies expressing various transgenes by *hs-gal4* was scored 50 h after heatshock induction of transgene expression. \*: *p*\<0.05 when compared to flies in null *ago2* background;. Statistics: ANOVA and Newman-Keuls post-test. Genotype of flies: *hs-gal4* in trans to: *UAS-DsRed-(CAG)34 UAS-DsRed- (CTG)19*, *UAS-DsRed-(CAG)250/ UAS-DsRed-(CAG)250*, *UAS-DsRed-(CTG)250/UAS-DsRed-(CTG)250*, *UAS-DsRed-(CAG)250 UAS-DsRed-(CAG)270* in either wildtype or *ago2* null background. (B) Internal eye degeneration of (CTG)200/(CAG)250 is suppressed in *ago2* null flies. 1d animals. Genotypes: *gmr-gal4* in trans to *UAS-DsRed-(CAG)250 UAS-DsRed-(CTG)200* in normal or homozygous *ago2* null background. 29 °C.

(0.57 MB TIF)

###### 

Click here for additional data file.

###### 

Upregulation of *dcr2* enhances toxicity of (CTG)200/(CAG)250 and increases levels of triplet repeat derived small RNAs in flies expressing (CTG)130/(CAG)100. (A) Flies coexpressing expanded CAG/CTG transcripts with added *dcr2* activity showed severe eye disruption. In contrast, upregulation of *dcr1* had little effect. Genotypes: from left to right *gmr-gal4 UAS-DsRed-(CTG)200; UAS-DsRed-(CAG)250* in trans to *w^1118^, UAS-dcr*2 and *UAS-dcr1*. (B) *Dcr2* upregulation increases levels of triplet repeat derived small RNAs. Genotype of flies: *hs-gal4*/*UAS-DsRed-(CAG)100 UAS-DsRed-(CTG)130* either with or without *UAS-dcr2.*

(1.88 MB TIF)

###### 

Click here for additional data file.

###### 

Fly genes that contain CAG or CUG repeats. List of fly genes that contain 7 or more CAG or CUG repeats in at least one of the splicing variants was obtained by performing a BLAST search of the *Drosophila melanogaster* Refseq_RNA database using (CAG)7 as the query sequence. Gene accession numbers were converted to gene names using the Gene ID Conversion Tool (<http://david.abcc.ncifcrf.gov/conversion.jsp>).

(0.23 MB DOC)

###### 

Click here for additional data file.

###### 

Human genes that contain CAG or CUG repeats. List of human genes that contain 7 or more CAG or CUG repeats in at least one of the splicing variants was obtained by performing a BLAST search of the *Homo sapiens* Refseq_RNA database using (CAG)7 as the query sequence. Gene accession numbers were converted to gene names using the Gene ID Conversion Tool (<http://david.abcc.ncifcrf.gov/conversion.jsp>).

(0.19 MB DOC)

###### 

Click here for additional data file.
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